RA Capital Management, L.P. 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-31 4:54 pm Purchase |
2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,684,890 20.100% |
7,750 (+0.07%) |
Filing |
| 2024-11-13 6:04 pm Purchase |
2024-11-08 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,677,140 21.100% |
586,069 (+5.81%) |
Filing |
| 2024-10-22 5:11 pm Sale |
2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,091,071 19.990% |
-384,418 (-3.67%) |
Filing |
| 2024-02-06 4:40 pm Purchase |
2024-02-06 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,475,489 19.990% |
3,239,035 (+44.76%) |
Filing |
| 2021-09-27 4:30 pm Purchase |
2021-09-17 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 7,236,454 17.000% |
7,236,454 (New Position) |
Filing |